Compare Metis (METIS) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Metis vs Mira — how do they compare? Metis trades at Rp42,395 (market cap Rp326,65M, Rp22,61M 24h volume), while Mira trades at Rp698.38 (market cap Rp224,01M, Rp102,95M 24h volume). The key difference: Metis is the larger of the two by market cap, and Metis's circulating supply is 7,7M / 10M METIS (78%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Metis for 77 Days and Mira for 22 Days on average.
| METIS | MIRA | |
|---|---|---|
Market Cap | Rp326,65M | Rp224,01M |
Volume (24h) | Rp22,61M | Rp102,95M |
Circulating Supply | 7,7M / 10M METIS (78%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 77 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Metis is currently trading at Rp42,985 with a bearish technical signal, showing weak momentum below key resistance levels. The token faces selling pressure with moving averages indicating a downtrend, though oscillators remain neutral. With 78% of the 10 million max supply in circulation and an average hold time of 77 days, the asset shows moderate distribution stability. Recent ecosystem developments include ongoing protocol upgrades to enhance Layer 2 scalability and reduce transaction costs.
Overall outlook remains cautious with technical weakness dominating. Key opportunities lie in potential Layer 2 adoption growth, while major risks include continued bearish momentum and crypto market volatility. Investors should monitor support at Rp41,711 for potential breakdown scenarios.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Metis
Metis is an Ethereum Layer-2 scaling solution aiming to solve the blockchain trilemma: that blockchains cannot be decentralized, secure, and scalable simultaneously. It also strives to solve Ethereum's biggest challenges: speed, cost and scalability.
Read more on METIS →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
